Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Lannach Chemical Co., Ltd. is a pharmaceutical manufacturing enterprise based in Chengdu, China, specializing in the production of high-quality Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. The company operates as a strategic manufacturing hub for the Austrian pharmaceutical group G.L. Pharma, ensuring that its production processes meet stringent international GMP standards. Its core expertise lies in complex small molecule synthesis, with a product portfolio heavily focused on therapeutic areas such as cardiovascular health, metabolic disorders, and oncology. Sichuan Lannach provides comprehensive Contract Development and Manufacturing Organization (CDMO) services, supporting global partners from early-stage process development through to commercial-scale supply. By combining European pharmaceutical heritage with local manufacturing advantages, the company has established itself as a reliable supplier in the global generic drug market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Lannach Chemical.